These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 19180157)
41. Has acetylcysteine use changed the incidence of contrast nephropathy in hospitalized patients? A before-after study. Shah SJ; Hsu CY Am J Med; 2004 Dec; 117(12):948-52. PubMed ID: 15629734 [No Abstract] [Full Text] [Related]
42. [Progression prevention, diagnosis, and treatment of contrast agent-induced nephropathy]. Potekhin NP; Nikitin AV; Evsiukov KB; Klopotskiĭ SA; Zaĭtseva EA Voen Med Zh; 2009 Jun; 330(6):27-32. PubMed ID: 19791685 [No Abstract] [Full Text] [Related]
43. Recent issues in contrast-induced nephropathy. Kitajima K; Maeda T; Watanabe S; Sugimura K Int J Urol; 2011 Oct; 18(10):686-90. PubMed ID: 21834851 [TBL] [Abstract][Full Text] [Related]
45. [Clinical doctors should pay attention to contrast-induced nephropathy]. Guo W Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1153-4. PubMed ID: 20646557 [No Abstract] [Full Text] [Related]
46. Nephropathy in critically Ill patients without preexisting renal disease. Polena S; Yang S; Alam R; Gricius J; Gupta JR; Badalova N; Chuang P; Gintautas J; Conetta R Proc West Pharmacol Soc; 2005; 48():134-5. PubMed ID: 16416679 [TBL] [Abstract][Full Text] [Related]
47. Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Bettmann MA Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i12-17. PubMed ID: 15705943 [No Abstract] [Full Text] [Related]
48. [Therapeutic strategy for prevention of contrast-induced nephropathy]. Suzuki H Nihon Rinsho; 2011 Sep; 69 Suppl 7():220-5. PubMed ID: 22518995 [No Abstract] [Full Text] [Related]
49. When to test renal function to disclose contrast-induced nephropathy. Aguiar-Souto P; Valero-González S Am J Cardiol; 2008 Aug; 102(3):371. PubMed ID: 18638608 [No Abstract] [Full Text] [Related]
50. Prophylaxis against contrast-induced nephropathy. Oliveira DB Lancet; 1999 May; 353(9165):1638-9. PubMed ID: 10335780 [No Abstract] [Full Text] [Related]
51. Contrast-associated nephropathy--old clinical problem and new therapeutic perspectives. Deray G Nephrol Dial Transplant; 1998 Nov; 13(11):2976-7. PubMed ID: 9829522 [No Abstract] [Full Text] [Related]
52. [Image contrasting nephropathy in patients with NIDDM: risk factors]. Gordeev AV; Sura VV Klin Med (Mosk); 1998; 76(11):34-6. PubMed ID: 10050530 [No Abstract] [Full Text] [Related]
53. The incidence and predictors of contrast-induced nephropathy in adequately hydrated elderly patients with impaired renal function. Park KW; Koo BK; Kim HL; Kim YS; Jo SH; Lee HY; Kang HJ; Cho YS; Chung WY; Yeon TJ; Chae IH; Choi DJ; Kim HS; Oh BH; Park YB Nephrol Dial Transplant; 2007 Jun; 22(6):1794-5. PubMed ID: 17324945 [No Abstract] [Full Text] [Related]
55. [Nephropathy induced by a contrast medium--comments on risk factors and prevention]. Aurell M; Boijsen M Lakartidningen; 1992 Jun; 89(24):2180. PubMed ID: 1630247 [No Abstract] [Full Text] [Related]
56. Investigating the volume status before contrast nephropathy studies. Toprak O; Cirit M Nephrol Dial Transplant; 2005 Feb; 20(2):464; author reply 464-6. PubMed ID: 15673702 [No Abstract] [Full Text] [Related]
57. Review of contrast-induced nephropathy and current use of N-acetylcysteine (NAC). Anwar M; Ledger S CANNT J; 2005; 15(1):33-8,quiz 38-9. PubMed ID: 15909775 [No Abstract] [Full Text] [Related]
58. Contrast-induced nephropathy and dehydration. Fox AJ; Symons SP; Aviv RI Can Assoc Radiol J; 2013 Aug; 64(3):275. PubMed ID: 23664209 [No Abstract] [Full Text] [Related]
59. [Contrast agent nephropathy is still a reality]. Nyman U; Aspelin P Lakartidningen; 2017 Mar; 114():. PubMed ID: 28323309 [No Abstract] [Full Text] [Related]